相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel Approaches to Epigenetic Therapies: From Drug Combinations to Epigenetic Editing
Aleksandra Majchrzak-Celinska et al.
GENES (2021)
Epigenetic mechanisms in breast cancer therapy and resistance
Liliana Garcia-Martinez et al.
NATURE COMMUNICATIONS (2021)
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Kunal Nepali et al.
JOURNAL OF BIOMEDICAL SCIENCE (2021)
Design, Synthesis, and Biological Evaluation of Quinazolin-4-one-Based Hydroxamic Acids as Dual PI3K/HDAC Inhibitors
Ashish Thakur et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells
Annalisa Romanelli et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
A New Family of Jumonji C Domain-Containing KDM Inhibitors Inspired by Natural Product Purpurogallin
Jose A. Souto et al.
FRONTIERS IN CHEMISTRY (2020)
Characterization of a dualBET/HDACinhibitor for treatment of pancreatic ductal adenocarcinoma
Xin Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Recent progress on cheminformatics approaches to epigenetic drug discovery
Zoe Sessions et al.
DRUG DISCOVERY TODAY (2020)
Histone Variants: Guardians of Genome Integrity
Juliette Ferrand et al.
CELLS (2020)
Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas
Jennifer K. Lue et al.
CLINICAL CANCER RESEARCH (2019)
Genome-wide Kdm4 histone demethylase transcriptional regulation in Drosophila
Amy Tsurumi et al.
MOLECULAR GENETICS AND GENOMICS (2019)
The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance
Karl Agger et al.
BLOOD (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
The Histone Demethylase Enzymes KDM3A and KDM4B Co-Operatively Regulate Chromatin Transactions of the Estrogen Receptor in Breast Cancer
Dominic Jones et al.
CANCERS (2019)
Histone Demethylase KDM4B Promotes DNA Damage by Activating Long Interspersed Nuclear Element-1
Ying Xiang et al.
CANCER RESEARCH (2019)
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast Cancer
Rosaria Benedetti et al.
CANCERS (2019)
The timeline of epigenetic drug discovery: from reality to dreams
A. Ganesan et al.
CLINICAL EPIGENETICS (2019)
H3K9 demethylase KDM4E is an epigenetic regulator for bovine embryonic development and a defective factor for nuclear reprogramming
Xin Liu et al.
DEVELOPMENT (2018)
Small molecule KDM4s inhibitors as anti-cancer agents
Hongzhi Lin et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
Jay H. Kalin et al.
NATURE COMMUNICATIONS (2018)
The JmjN domain as a dimerization interface and a targeted inhibitor of KDM4 demethylase activity
May Levin et al.
Oncotarget (2018)
CTCF-KDM4A complex correlates with histone modifications that negatively regulate CHD5 gene expression in cancer cell lines
Lissania Guerra-Calderas et al.
Oncotarget (2018)
KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancer
Wenyu Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling
Fuqing Hu et al.
MOLECULAR CANCER (2018)
Fbxo22-mediated KDM4B degradation determines selective estrogen receptor modulator activity in breast cancer
Yoshikazu Johmura et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer
C. Wilson et al.
ONCOGENE (2017)
Design of KDM4 Inhibitors with Antiproliferative Effects in Cancer Models
Young K. Chen et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Assessing histone demethylase inhibitors in cells: lessons learned
Stephanie B. Hatch et al.
EPIGENETICS & CHROMATIN (2017)
Highly selective inhibition of histone demethylases by de novo macrocyclic peptides
Akane Kawamura et al.
NATURE COMMUNICATIONS (2017)
KDM4B histone demethylase and G9a regulate expression of vascular adhesion proteins in cerebral microvessels
Ji-Young Choi et al.
SCIENTIFIC REPORTS (2017)
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer
Christos Damaskos et al.
ANTICANCER RESEARCH (2017)
KDM4 Inhibition Targets Breast Cancer Stem-like Cells
Eric Metzger et al.
CANCER RESEARCH (2017)
Maternal expression of the histone demethylase Kdm4a is crucial for pre-implantation development
Aditya Sankar et al.
DEVELOPMENT (2017)
Jumonji domain containing 2A predicts prognosis and regulates cell growth in lung cancer depending on miR-150
Weihua Xu et al.
ONCOLOGY REPORTS (2016)
Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth
Rajneesh Pathania et al.
CANCER RESEARCH (2016)
Silencing the epigenetic silencer KDM4A for TRAIL and DR5 simultaneous induction and antitumor therapy
Junjian Wang et al.
CELL DEATH AND DIFFERENTIATION (2016)
Regulation of Transient Site-specific Copy Gain by MicroRNA
Joshua C. Black et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Identification of family determining residues in Jumonji-C lysine demethylases: A sequence-based, family wide classification
Patrick Slama
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2016)
Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance
Molly Gale et al.
ONCOTARGET (2016)
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers
Jeannine Diesch et al.
CLINICAL EPIGENETICS (2016)
Deletion of JMJD2B in neurons leads to defective spine maturation, hyperactive behavior and memory deficits in mouse
K. Fujiwara et al.
TRANSLATIONAL PSYCHIATRY (2016)
KDM4C Activity Modulates Cell Proliferation and Chromosome Segregation in Triple-Negative Breast Cancer
Jeison Garcia et al.
BREAST CANCER-BASIC AND CLINICAL RESEARCH (2016)
The emerging role of lysine demethylases in DNA damage response: dissecting the recruitment mode of KDM4D/JMJD2D to DNA damage sites
Hanan Khoury-Haddad et al.
CELL CYCLE (2015)
KDM4/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes
Lingling Duan et al.
CHEMISTRY & BIOLOGY (2015)
Histone demethylase JMJD2B and JMJD2C induce fibroblast growth factor 2: mediated tumorigenesis of osteosarcoma
Xiaojiang Li et al.
MEDICAL ONCOLOGY (2015)
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Katarzyna Tomczak et al.
Wspolczesna Onkologia-Contemporary Oncology (2015)
DNA repair mechanisms in cancer development and therapy
Alessandro Torgovnick et al.
FRONTIERS IN GENETICS (2015)
KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review
Young-Won Chin et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Substrate- and Cofactor-independent Inhibition of Histone Demethylase KDM4C
Ulrike Leurs et al.
ACS CHEMICAL BIOLOGY (2014)
JMJD2A-dependent silencing of Sp1 in advanced breast cancer promotes metastasis by downregulation of DIRAS3
Liliang Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Global Gene Repression by the Steroid Receptor Coactivator SRC-1 Promotes Oncogenesis
Claire A. Walsh et al.
CANCER RESEARCH (2014)
Distinct and Combinatorial Functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in Mouse Embryonic Stem Cell Identity
Partha Pratim Das et al.
MOLECULAR CELL (2014)
A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer
Qi Hong et al.
ONCOTARGET (2014)
JMJD2A contributes to breast cancer progression through transcriptional repression of the tumor suppressor ARHI
Li-Liang Li et al.
BREAST CANCER RESEARCH (2014)
Investigations on the oxygen dependence of a 2-oxoglutarate histone demethylase
Elena M. Sanchez-Fernandez et al.
BIOCHEMICAL JOURNAL (2013)
KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer Cells
William L. Berry et al.
CANCER RESEARCH (2013)
KDM4A Lysine Demethylase Induces Site-Specific Copy Gain and Rereplication of Regions Amplified in Tumors
Joshua C. Black et al.
CELL (2013)
Histone lysine demethylases in breast cancer
Elisa Paolicchi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
The Trithorax Group Protein Ash2l Is Essential for Pluripotency and Maintaining Open Chromatin in Embryonic Stem Cells
Ma Wan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Pan-cancer patterns of somatic copy number alteration
Travis I. Zack et al.
NATURE GENETICS (2013)
KDM4B is a Master Regulator of the Estrogen Receptor Signalling Cascade
Luke Gaughan et al.
NUCLEIC ACIDS RESEARCH (2013)
Histone demethylase GASC1 - a potential prognostic and predictive marker in invasive breast cancer
Bozena Berdel et al.
BMC CANCER (2012)
HIF-1α-induced histone demethylase JMJD2B contributes to the malignant phenotype of colorectal cancer cells via an epigenetic mechanism
Linna Fu et al.
CARCINOGENESIS (2012)
Histone Demethylases KDM4B and KDM6B Promote Osteogenic Differentiation of Human MSCs
Ling Ye et al.
CELL STEM CELL (2012)
Oncogenic features of the JMJD2A histone demethylase in breast cancer
William L. Berry et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
The JMJD2A demethylase regulates apoptosis and proliferation in colon cancer cells
Tae-Dong Kim et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2012)
Cell-Type-Specific Control of Enhancer Activity by H3K9 Trimethylation
Yina Zhu et al.
MOLECULAR CELL (2012)
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact
Joshua C. Black et al.
MOLECULAR CELL (2012)
Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability
R. B. Slee et al.
ONCOGENE (2012)
Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D
Tae-Dong Kim et al.
PLOS ONE (2012)
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
Weibo Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Effects of siRNA-mediated knockdown of jumonji domain containing 2A on proliferation, migration and invasion of the human breast cancer cell line MCF-7
Bei-Xu Li et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
JMJD2A Promotes Cellular Transformation by Blocking Cellular Senescence through Transcriptional Repression of the Tumor Suppressor CHD5
Frederick A. Mallette et al.
CELL REPORTS (2012)
Overexpression of CXCL5 Is Associated With Poor Survival in Patients With Pancreatic Cancer
Aihua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
The Testis-Enriched Histone Demethylase, KDM4D, Regulates Methylation of Histone H3 Lysine 9 During Spermatogenesis in the Mouse but Is Dispensable for Fertility
Naoki Iwamori et al.
BIOLOGY OF REPRODUCTION (2011)
Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family
Lars Hillringhaus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Effects of RNA interference-mediated gene silencing of JMJD2A on human breast cancer cell line MDA-MB-231 in vitro
Bei-Xu Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
A Selective Inhibitor and Probe of the Cellular Functions of Jumonji C Domain-Containing Histone Demethylases
Xuelai Luo et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
SCFFBXO22 Regulates Histone H3 Lysine 9 and 36 Methylation Levels by Targeting Histone Demethylase KDM4A for Ubiquitin-Mediated Proteasomal Degradation
Meng-Kwang Marcus Tan et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
A conditional knockout resource for the genome-wide study of mouse gene function
William C. Skarnes et al.
NATURE (2011)
Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development
Masahito Kawazu et al.
PLOS ONE (2011)
Molecular Recognition of H3/H4 Histone Tails by the Tudor Domains of JMJD2A: A Comparative Molecular Dynamics Simulations Study
Musa Ozboyaci et al.
PLOS ONE (2011)
Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis
Lei Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A New Isoform of the Histone Demethylase JMJD2A/KDM4A Is Required for Skeletal Muscle Differentiation
Laure Verrier et al.
PLOS GENETICS (2011)
Reversal of Histone Methylation: Biochemical and Molecular Mechanisms of Histone Demethylases
Nima Mosammaparast et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
The Histone Demethylase JMJD2C Is Stage-Specifically Expressed in Preimplantation Mouse Embryos and Is Required for Embryonic Development
Jianle Wang et al.
BIOLOGY OF REPRODUCTION (2010)
The Histone Demethylase JMJD2B Is Regulated by Estrogen Receptor α and Hypoxia, and Is a Key Mediator of Estrogen Induced Growth
Jun Yang et al.
CANCER RESEARCH (2010)
The JmjN Domain of Jhd2 Is Important for Its Protein Stability, and the Plant Homeodomain (PHD) Finger Mediates Its Chromatin Association Independent of H3K4 Methylation
Fu Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Combination Treatment with MEK and AKT Inhibitors Is More Effective than Each Drug Alone in Human Non-Small Cell Lung Cancer In Vitro and In Vivo
Jieru Meng et al.
PLOS ONE (2010)
Oncogenes and Tumor Suppressor Genes
Eva Y. H. P. Lee et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Dynamic Histone H1 Isotype 4 Methylation and Demethylation by Histone Lysine Methyltransferase G9a/KMT1C and the Jumonji Domain-containing JMJD2/KDM4 Proteins
Patrick Trojer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
G. Liu et al.
ONCOGENE (2009)
Cellular roles of ADAM12 in health and disease
Marie Kveiborg et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
The Histone Demethylases JMJD1A and JMJD2B Are Transcriptional Targets of Hypoxia-inducible Factor HIF
Sophie Beyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma
Emily H. Smith et al.
HUMAN MOLECULAR GENETICS (2007)
Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D
Sook Shin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression
Melanie Wissmann et al.
NATURE CELL BIOLOGY (2007)
Notch expression patterns in the retina: An eye on receptor-ligand distribution during angiogenesis
Jennifer J. Hofmann et al.
GENE EXPRESSION PATTERNS (2007)
Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases
Johnathan R. Whetstine et al.
CELL (2006)
JmjC-domain-containing proteins and histone demethylation
Robert J. Klose et al.
NATURE REVIEWS GENETICS (2006)
JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2)
DZ Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Estrogen receptor-β is critical to granulosa cell differentiation and the ovulatory response to gonadotropins
JF Couse et al.
ENDOCRINOLOGY (2005)
In vitro growth and ovulation of follicles from ovaries of estrogen receptor (ER)α and ERβ null mice indicate a role for ERβ in follicular maturation
JMA Emmen et al.
ENDOCRINOLOGY (2005)
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3
P George et al.
BLOOD (2005)
分享论文
